Posted 30 April 2016
We have previously written about the MCC claiming that they will be taking action against “scores of illegal products claiming to treat diabetes, heart disease, cancer and viral illnesses in a blitz aimed at enforcing tough regulations for complementary medicines”. Products claiming to be effective in insulin control or diabetes, had to apply for registration. They will be evaluated to see whether their claims are justified, and the product safe, before registration is granted. Else they have to disappear from the market. Products that have applied for registration include the Medical Nutritional Institute’s AntaGolin, Brunel Laboratories’ Patrick Holford Cinnamon and Avid Brands’ Bioharmony Cinnabalance. We have argued that Antagolin’s evidence is problematic, and that the ingredients and dose in Holford’s Cinnamon inadequate to support their claims. We wait the MCC’s decision.
The U.S.A. Food and Drug Administration (FDA) have released a media release warning against … Read the rest
